RESULTS
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board approved audited standalone and consolidated results for Q4 and FY ended March 31, 2025. Total income for FY25 stood at ₹4,421.82 lakhs versus ₹23,967.85 lakhs in FY24, a sharp drop mainly due to lower capital market operations revenue. Net profit after tax fell to ₹117.96 lakhs (FY25) from ₹241.09 lakhs (FY24), with basic EPS at ₹2.07 vs ₹4.32. Q4 alone was mixed, with total income rising to ₹1,115.66 lakhs (vs ₹782.77 lakhs) but profit declining to ₹29.44 lakhs (vs ₹67.50 lakhs). The board also recorded an exceptional item of ₹58.53 lakhs as a provision for an old sub-judice deposit with the City Civil Court, Bombay. Director Mr. Ajay Kumar Kayan resigned for personal reasons, and Mr. Saharsh Parekh was appointed as an Additional Non-Executive Promoter Director. Sudhansu Sekhar Panigrahi was appointed as Secretarial Auditor for five years (FY26–FY30), subject to shareholder approval.
Sharply lower FY25 revenue and profits signal weaker capital market activity YoY, which may weigh on sentiment. The entry of a promoter family member (son of the Chairman and brother of the Joint MD) onto the board further concentrates family control, while pending warrants from the October 2024 preferential allotment could dilute existing shareholders if converted.